Committee Charters

Clinical Science
Chair, Jeffrey Cossman, M.D.
The Clinical Science Committee was created to evaluate the emerging applications of science and technology in personalized medicine. It serves as an advisory resource for the PMC, and helps guide policies and statements by the organization in its effort to advance personalized medicine in the public sphere. The Committee also oversees material published on the PMC's web sites and in its other publications. Dr. Cossman, the Chief Scientific Officer of the Critical Path Institute (C-Path), has been on the cutting edge of research in personalized medicine for the last two decades. He helped found the field of molecular diagnostics, which has grown to become a major tool in personalized medicine, while at the National Cancer Institute and at Georgetown University Medical Center, where he served as Chairman of the Department of Pathology. Prior to joining C-Path, he was Vice President of Gene Logic, Inc., where he directed scientific and academic collaborations using microarray gene expression.

Public Policy
Chair, Robert Wells, HealthFutures, LLC
The Public Policy Committee governs, under a set of rules previously established by the PMC Board, the adoption of all of the organization's public policy positions, and oversees the strategies by which they are communicated to target audiences, including all branches of the federal government as well as other non-governmental agencies.